Have a personal or library account? Click to login
Rationale and Design of a Multi-National Study of Physicians’ Opinions, Attitudes, and Practices Regarding Influenza Vaccination in Patients with Cardiovascular Diseases: A Mixed Methods Designs. The FLUence Project Cover

Rationale and Design of a Multi-National Study of Physicians’ Opinions, Attitudes, and Practices Regarding Influenza Vaccination in Patients with Cardiovascular Diseases: A Mixed Methods Designs. The FLUence Project

Global Heart
Volume 19 (2024): Issue 1
By: Sebastián Garcia-Zamora,  Angela S. Koh,  Svetlana Stoica,  Nariman Sepehrvand,  Harish Ranjani,  Salisu Ishaku,  Naomi Herz,  Vanessa Kandoole-Kabwere,  Pablo Perel,  Amitava Banerjee,  Charlotte Warren-Gash,  Sean Taylor,  Daniel José Piñeiro,  María Inés Sosa-Liprandi and  Álvaro Sosa-Liprandi  
Open Access
|Oct 2024

References

  1. 1Garcia-Zamora S, Pulido L. Vaccines in cardiology, an underutilized strategy to reduce the residual cardiovascular risk. Arch Peru Cardiol Cir Cardiovasc. 2024; 5(1):29–39. DOI: 10.47487/apcyccv.v5i1.349
    Back to article
  2. 2Hinman AR. 1889 to 1989: a century of health and disease. Public Health Rep. 1990; 105(4):374–80.
    Back to article
  3. 3Sosa-Liprandi MI, Zaidel EJ, Sosa-Liprandi A. A recent experience on the role of influenza vaccination on cardiovascular events. Eur Heart J Suppl. 2023; 25(Suppl A):A31–A5. DOI: 10.1093/eurheartjsupp/suac111
    Back to article
  4. 4Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020; 76(25):2982–3021. DOI: 10.1016/j.jacc.2020.11.010
    Back to article
  5. 5Bowry AD, Lewey J, Dugani SB, Choudhry NK. The burden of cardiovascular disease in low- and middle-income countries: Epidemiology and management. Can J Cardiol. 2015; 31(9):1151–9. DOI: 10.1016/j.cjca.2015.06.028
    Back to article
  6. 6Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: Prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol. 1984; 53(4):481–2. DOI: 10.1016/0002-9149(84)90016-X
    Back to article
  7. 7Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988; 2(8618):983–6. DOI: 10.1016/S0140-6736(88)90741-6
    Back to article
  8. 8Mattila KJ, Nieminen MS, Valtonen VV, Rasi VP, Kesaniemi YA, Syrjala SL, et al. Association between dental health and acute myocardial infarction. BMJ. 1989; 298(6676):779–81. DOI: 10.1136/bmj.298.6676.779
    Back to article
  9. 9Syrjanen J, Valtonen VV, Iivanainen M, Kaste M, Huttunen JK. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J (Clin Res Ed). 1988; 296(6630):1156–60. DOI: 10.1136/bmj.296.6630.1156
    Back to article
  10. 10Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004; 351(25):2611–8. DOI: 10.1056/NEJMoa041747
    Back to article
  11. 11Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009; 9(10):601–10. DOI: 10.1016/S1473-3099(09)70233-6
    Back to article
  12. 12Warren-Gash C, Bhaskaran K, Hayward A, Leung GM, Lo SV, Wong CM, et al. Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong. J Infect Dis. 2011; 203(12):1710–8. DOI: 10.1093/infdis/jir171
    Back to article
  13. 13Warren-Gash C, Blackburn R, Whitaker H, McMenamin J, Hayward AC. Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland. Eur Respir J. 2018; 51(3). DOI: 10.1183/13993003.01794-2017
    Back to article
  14. 14Garcia-Zamora S, Lee S, Haseeb S, Bazoukis G, Tse G, Alvarez-Garcia J, et al. Arrhythmias and electrocardiographic findings in Coronavirus disease 2019: A systematic review and meta-analysis. Pacing Clin Electrophysiol. 2021; 44(6):1062–74. DOI: 10.1111/pace.14247
    Back to article
  15. 15Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: Case-control study through a general practice database. Eur Heart J. 2008; 29(1):96–103. DOI: 10.1093/eurheartj/ehm516
    Back to article
  16. 16Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018; 378(4):345–53. DOI: 10.1056/NEJMoa1702090
    Back to article
  17. 17Corrales-Medina VF, Serpa J, Rueda AM, Giordano TP, Bozkurt B, Madjid M, et al. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine (Baltimore). 2009; 88(3):154–9. DOI: 10.1097/MD.0b013e3181a692f0
    Back to article
  18. 18Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012; 125(6):773–81. DOI: 10.1161/CIRCULATIONAHA.111.040766
    Back to article
  19. 19Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med. 2008; 168(8):847–54. DOI: 10.1001/archinte.168.8.847
    Back to article
  20. 20Alvarez PA, Briasoulis A, Malik AH. Frequency and impact of infectious disease conditions diagnosed during decompensated heart failure hospitalizations in the United States. Am J Cardiol. 2023; 191:1–7. DOI: 10.1016/j.amjcard.2022.12.001
    Back to article
  21. 21Kujawski SA, Whitaker M, Ritchey MD, Reingold AL, Chai SJ, Anderson EJ, et al. Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure-United States, 2015–2017. PLoS One. 2022; 17(3):e0264890. DOI: 10.1371/journal.pone.0264890
    Back to article
  22. 22Surie D, Yuengling KA, DeCuir J, Zhu Y, Lauring AS, Gaglani M, et al. Severity of respiratory syncytial virus vs COVID-19 and influenza among hospitalized US adults. JAMA Netw Open. 2024; 7(4):e244954.
    Back to article
  23. 23Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013; 310(16):1711–20. DOI: 10.1001/jama.2013.279206
    Back to article
  24. 24Barnes M, Heywood AE, Mahimbo A, Rahman B, Newall AT, Macintyre CR. Acute myocardial infarction and influenza: a meta-analysis of case-control studies. Heart. 2015; 101(21):1738–47. DOI: 10.1136/heartjnl-2015-307691
    Back to article
  25. 25Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015; 2015(5):CD005050. DOI: 10.1002/14651858.CD005050.pub3
    Back to article
  26. 26Yedlapati SH, Khan SU, Talluri S, Lone AN, Khan MZ, Khan MS, et al. Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: A systematic review and meta-analysis. J Am Heart Assoc. 2021; 10(6):e019636. DOI: 10.1161/JAHA.120.019636
    Back to article
  27. 27Frobert O, Gotberg M, Erlinge D, Akhtar Z, Christiansen EH, MacIntyre CR, et al. Influenza vaccination after myocardial infarction: A randomized, double-blind, placebo-controlled, multicenter trial. Circulation. 2021; 144(18):1476–84. DOI: 10.1161/CIRCULATIONAHA.121.057042
    Back to article
  28. 28Garcia-Zamora S, Sosa Liprandi MI, Picco JM, Matta MG, Villarreal R, Pulido L, et al. Immunizations in adults with cardiovascular disease. Summary of the consensus of the Argentine Cardiology Society. Medicina (B Aires). 2020; 80(5):541–53.
    Back to article
  29. 29Liprandi AS, Liprandi MIS, Zaidel EJ, Aisenberg GM, Baranchuk A, Barbosa ECD, et al. Influenza vaccination for the prevention of cardiovascular disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation. Glob Heart. 2021; 16(1):55. DOI: 10.5334/gh.1069
    Back to article
  30. 30Davis MM, Taubert K, Benin AL, Brown DW, Mensah GA, Baddour LM, et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation. 2006; 114(14):1549–53. DOI: 10.1161/CIRCULATIONAHA.106.178242
    Back to article
  31. 31Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3):407–77. DOI: 10.1093/eurheartj/ehz425
    Back to article
  32. 32Matta MG, Pulido L, Herrera-Paz JJ, Picco JM, Wolff S, Tse G, et al. Influenza and pneumococcal vaccine prescription for adults during COVID-19 first wave in three regions of Argentina. Vaccine. 2023; 41(9):1541–4. DOI: 10.1016/j.vaccine.2023.01.056
    Back to article
  33. 33Sosa Liprandi A, Zaidel EJ, Lopez Santi R, Araujo JJ, Banos Gonzalez MA, Busso JM, et al. Influenza and pneumococcal vaccination in non-infected cardiometabolic patients from the Americas during the COVID-19 pandemic. A sub-analysis of the CorCOVID-LATAM study. Vaccines (Basel). 2021; 9(2). DOI: 10.3390/vaccines9020123
    Back to article
  34. 34Vardeny O, Claggett B, Udell JA, Packer M, Zile M, Rouleau J, et al. Influenza vaccination in patients with chronic heart failure: The PARADIGM-HF trial. JACC Heart Fail. 2016; 4(2):152–8. DOI: 10.1016/j.jchf.2015.10.012
    Back to article
  35. 35Palache A, Oriol-Mathieu V, Abelin A, Music T, Influenza Vaccine Supply task force. Seasonal influenza vaccine dose distribution in 157 countries (2004–2011). Vaccine. 2014; 32(48):6369–76. DOI: 10.1016/j.vaccine.2014.07.012
    Back to article
  36. 36Dang A, Sharma J. Assessing the low influenza vaccination coverage rate among healthcare personnel in India: A review of obstacles, beliefs, and strategies. Value Health Reg Issues. 2020; 21:100–4. DOI: 10.1016/j.vhri.2019.08.480
    Back to article
  37. 37Sundaram N, Purohit V, Schaetti C, Kudale A, Joseph S, Weiss MG. Community awareness, use and preference for pandemic influenza vaccines in Pune, India. Hum Vaccin Immunother. 2015; 11(10):2376–88. DOI: 10.1080/21645515.2015.1062956
    Back to article
  38. 38Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med. 2008; 121(7 Suppl 2):S28–35. DOI: 10.1016/j.amjmed.2008.05.005
    Back to article
  39. 39Sharma A, Minh Duc NT, Luu Lam Thang T, Nam NH, Ng SJ, Abbas KS, et al. A Consensus-Based Checklist for Reporting of Survey Studies (CROSS). J Gen Intern Med. 2021; 36(10):3179–87. DOI: 10.1007/s11606-021-06737-1
    Back to article
  40. 40Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004; 6(3):e34. DOI: 10.2196/jmir.6.3.e34
    Back to article
  41. 41World-Health-Organization. Behavioural and social drivers of vaccination: tools and practical guidance for achieving high uptake [Internet]. 2022. Available from: https://www.who.int/publications/i/item/9789240049680.
    Back to article
  42. 42Jiang B, Cao Y, Qian J, Jiang M, Huang Q, Sun Y, et al. Healthcare workers’ attitudes toward influenza vaccination: A behaviour and social drivers survey. Vaccines (Basel). 2023; 11(1). DOI: 10.3390/vaccines11010143
    Back to article
  43. 43Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19(6):349–57. DOI: 10.1093/intqhc/mzm042
    Back to article
  44. 44Ridda I, Lindley IR, Gao Z, McIntyre P, Macintyre CR. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people. Vaccine. 2008; 26(44):5633–40. DOI: 10.1016/j.vaccine.2008.07.070
    Back to article
  45. 45Wennekes MD, Almasi T, Eilers R, Mezei F, Petyko ZI, Timen A, et al. Effectiveness of educational interventions for healthcare workers on vaccination dialogue with older adults: a systematic review. Arch Public Health. 2024; 82(1):34. DOI: 10.1186/s13690-024-01260-1
    Back to article
  46. 46Montone RA, Camilli M, Calvieri C, Magnani G, Bonanni A, Bhatt DL, et al. Exposome in ischaemic heart disease: beyond traditional risk factors. Eur Heart J. 2024; 45(6):419–38. DOI: 10.1093/eurheartj/ehae001
    Back to article
  47. 47Sun G, Zhang L, Qiu Y, Jia Y, Wang Y, Xu H, et al. Changes of influenza vaccination rate and associated influencing factors after the COVID-19 pandemic in Shanghai, China. Hum Vaccin Immunother. 2024; 20(1):2287294. DOI: 10.1080/21645515.2023.2287294
    Back to article
  48. 48Lin J, Li C, He W. Trends in influenza vaccine uptake before and during the COVID-19 pandemic in the USA. Public Health. 2023; 225:291–8. DOI: 10.1016/j.puhe.2023.10.028
    Back to article
  49. 49UK-Health-Security-Agency. Seasonal influenza vaccine uptake in GP patients in England: winter season 2023 to 2024 [Internet]. UK Health Security Agency; Official Statistics Web page. Available from: https://www.gov.uk/government/statistics/seasonal-influenza-vaccine-uptake-in-gp-patients-winter-season-2023-to-2024/seasonal-influenza-vaccine-uptake-in-gp-patients-in-england-winter-season-2023-to-2024#contents.
    Back to article
DOI: https://doi.org/10.5334/gh.1358 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Jul 5, 2024
Accepted on: Sep 20, 2024
Published on: Oct 15, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
influenza,
vaccine,
inflammation,
cardiovascular disease,
survey

© 2024 Sebastián Garcia-Zamora, Angela S. Koh, Svetlana Stoica, Nariman Sepehrvand, Harish Ranjani, Salisu Ishaku, Naomi Herz, Vanessa Kandoole-Kabwere, Pablo Perel, Amitava Banerjee, Charlotte Warren-Gash, Sean Taylor, Daniel José Piñeiro, María Inés Sosa-Liprandi, Álvaro Sosa-Liprandi, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 19 (2024): Issue 1Next article